For clinics and healthcare
Better information may change how oncology care is followed.
Clinics, hospitals, health plans and care institutions can take part in research that investigates future detection and monitoring — before any clinical use.
Market opportunity
Oncology follow-up needs better information
Care teams make decisions over long journeys. Timely, accessible information about the patient's condition remains a recurring need.
- Long, complex oncology care journeys
- Need for accessible follow-up information
- Cost and access pressures for providers and payers
How DIASCI may contribute
Research today, possible adoption tomorrow
DIASCI seeks clinical partners for studies that generate the evidence needed to evaluate future detection and monitoring applications.
- Clinical research under ethics approval
- Study design aligned with care journeys
- Not a clinically validated tool
Potential applications and expected benefits
Possible future applications
Potential applicationDetection support
Future support for detection, if validated.
Monitoring over time
Possible follow-up of patients along treatment journeys.
Integration with care pathways
How results could fit existing clinical workflows.
Evidence and current stage
Adoption in care would only be possible after validation studies and the applicable regulatory requirements.
Technology
In development.
Clinical studies
Partners being sought.
Clinical use
Not approved for clinical use.
DIONCO and the AI platform are in development. Preliminary, company-reported findings support further assessment; clinical and regulatory validation is still required. No product is currently approved or commercially available.
Possible collaboration models
Exploratory possibilities only. Any model depends on mutual interest, due diligence and formal agreements.
Pilot projects
Clinical research and validation studies.
Co-development
Shaping applications with clinicians' input.
Future commercialization
Possible future adoption after validation and clearance.
Request a meeting
Request a Meeting with DIASCI
Tell us about your institution and research interests. Collaboration starts with studies, never with clinical use of an unvalidated tool.